Simplex Trading
EWTX icon

Simplex Trading’s Edgewise Therapeutics EWTX Stock Holding History

Simplex Trading’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.8K Buy
1,300
+400
+44% +$13.8K ﹤0.01% 6250
2026
Q1 		$28.4K Sell
900
-3,800
-81% -$110K ﹤0.01% 6447
2025
Q4 		$117K Buy
4,700
+2,700
+135% +$54.2K ﹤0.01% 4840
2025
Q3 		$32K Buy
2,000
+800
+67% +$11.3K ﹤0.01% 6905
2025
Q2 		$15K Sell
1,200
-134,700
-99% -$1.94M ﹤0.01% 7001
2025
Q1 		$2.99M Buy
135,900
+123,900
+1,033% +$3.25M ﹤0.01% 1666
2024
Q4 		$320K Sell
12,000
-56,700
-83% -$1.81M ﹤0.01% 4000
2024
Q3 		$1.83M Buy
68,700
+62,900
+1,084% +$1.25M ﹤0.01% 2347
2024
Q2 		$104K Buy
5,800
+5,600
+2,800% +$97.7K ﹤0.01% 5332
2024
Q1 		$3K Sell
200
-17,200
-99% -$273K ﹤0.01% 8247
2023
Q4 		$190K Buy
+17,400
New +$122K ﹤0.01% 4735

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Simplex Trading's EWTX Position: Q2 2026 in Review

Simplex Trading sold out of Edgewise Therapeutics (EWTX) in Q2 2026, closing a stake of 1,832 shares — an estimated $63.2K sold.

Simplex Trading first reported a position in EWTX in Q1 2023 and held it in 11 quarters. The position peaked at $1.98M in Q3 2024. 227 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Simplex Trading reported no remaining Edgewise Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 1,832 Edgewise Therapeutics shares in Q2 2026, an estimated $63.2K.
  • Simplex Trading first reported a position in Edgewise Therapeutics in Q1 2023 and held it in 11 quarters.
  • Simplex Trading's Edgewise Therapeutics position peaked at $1.98M in Q3 2024.
  • 227 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.